Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles

被引:159
作者
Unverferth, K
Engel, J
Höfgen, N
Rostock, A
Günther, R
Lankau, HJ
Menzer, M
Rolfs, A
Liebscher, J
Müller, B
Hofmann, HJ
机构
[1] Arzneimittelwerk Dresden GmbH, Corp Res & Dev ASTA Med Grp, D-01445 Radebeul, Germany
[2] Humboldt Univ, Dept Chem, D-10115 Berlin, Germany
[3] Univ Leipzig, Inst Biochem, Fac Biol Sci Pharm & Psychol, D-04103 Leipzig, Germany
关键词
D O I
10.1021/jm970327j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Starting from the corresponding acetophenone and glycine derivatives, a series of new 3-aminopyrroles was synthesized in few steps. Using this procedure with hydrazine and hydroxylamine instead of the glycinates provides access to S-aminopyrazoles and 5-amino-1,2-oxazoles. The various derivatives were tested for anticonvulsant activity in a variety of test models. Several compounds exhibit considerable activity with a remarkable lack of neurotoxicity. 4-(4-Bromophenyl)-3-morpholinopyrrole-2-carboxylic acid methyl ester, 3, proved to be the most active compound. It was protective in the maximal electroshock seizure (MES) test in rats with an oral ED50 of 2.5 mg/kg with no neurotoxicity noted at doses up to 500 mg/kg. Compound 3 blocks sodium channels in a frequency-dependent manner. The essential structural features which could be responsible for an interaction with an active site of the voltage-dependent sodium channel are established within a suggested pharmacophore model.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 58 条
[51]  
Swinyard E, 1989, ANTIEPILEPTIC DRUGS, P85
[52]   NA+ CHANNELS AS TARGETS FOR NEUROPROTECTIVE DRUGS [J].
TAYLOR, CP ;
MELDRUM, BS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (09) :309-316
[53]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF A MAMMALIAN SKELETAL-MUSCLE SODIUM-CHANNEL [J].
TRIMMER, JS ;
COOPERMAN, SS ;
TOMIKO, SA ;
ZHOU, JY ;
CREAN, SM ;
BOYLE, MB ;
KALLEN, RG ;
SHENG, ZH ;
BARCHI, RL ;
SIGWORTH, FJ ;
GOODMAN, RH ;
AGNEW, WS ;
MANDEL, G .
NEURON, 1989, 3 (01) :33-49
[54]  
*WAV INC, 1994, SPARTAN VERS 4 1
[55]  
WILLOW M, 1982, MOL PHARMACOL, V22, P627
[56]   CONFORMATIONAL-ANALYSIS OF CLINICALLY ACTIVE ANTICONVULSANT DRUGS [J].
WONG, MG ;
DEFINA, JA ;
ANDREWS, PR .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (04) :562-572
[57]   INTERACTION OF THE ANTIEPILEPTIC DRUG LAMOTRIGINE WITH RECOMBINANT RAT-BRAIN TYPE IIA NA+ CHANNELS AND WITH NATIVE NA+ CHANNELS IN RAT HIPPOCAMPAL-NEURONS [J].
XIE, XM ;
LANCASTER, B ;
PEAKMAN, T ;
GARTHWAITE, J .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1995, 430 (03) :437-446
[58]  
YAMAGAMI C, 1992, CHEM PHARM BULL, V40, P925